Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn G Baird

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 24, 2003
DX-88 and HAE: a developmental perspectiveAnthony Williams, Lynn G Baird
Therapeutic Innovation & Regulatory Science|September 22, 2018
Comparison of Stakeholder Metrics for Traditional and Adaptive Development and Licensing Approaches to Drug DevelopmentLynn G Baird, Mark R Trusheim, Hans-Georg Eichler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2017
Characterization of annual disease progression of multiple sclerosis patients: A population-based studyJonatan Freilich, Ali Manouchehrinia, Mark Trusheim, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to ImplementationDuane Schulthess, Lynn G Baird, Mark Trusheim, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis|October 24, 2003
DX-88 and HAE: a developmental perspectiveAnthony Williams, Lynn G Baird
Therapeutic Innovation & Regulatory Science|September 22, 2018
Comparison of Stakeholder Metrics for Traditional and Adaptive Development and Licensing Approaches to Drug DevelopmentLynn G Baird, Mark R Trusheim, Hans-Georg Eichler, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|May 9, 2017
Characterization of annual disease progression of multiple sclerosis patients: A population-based studyJonatan Freilich, Ali Manouchehrinia, Mark Trusheim, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Medicines Adaptive Pathways to Patients (MAPPs): A Story of International Collaboration Leading to ImplementationDuane Schulthess, Lynn G Baird, Mark Trusheim, et al.
Pageof 1